scholarly journals LAMB2 novel variant c.2885‐9 C>A affects RNA splicing in a minigene assay

2021 ◽  
Author(s):  
Xiaoyuan Wang ◽  
Huijie Xiao ◽  
Baige Su ◽  
Yali Ren ◽  
Jie Ding ◽  
...  
Keyword(s):  
Rna Splicing ◽  
Novel Variant ◽  
Minigene Assay

scholarly journals Identification of eight exonic variants in the SLC4A1, ATP6V1B1 and ATP6V0A4 gene that alter RNA splicing by minigene assay

2021 ◽  
Author(s):  
Ruixiao Zhang ◽  
Zeqing Chen ◽  
Qijing Song ◽  
Sai Wang ◽  
Zhiying Liu ◽  
...  
Keyword(s):  
Rna Splicing ◽  
Mrna Level ◽  
Exon Skipping ◽  
Regulatory Elements ◽  
Mrna Splicing ◽  
Splicing Regulatory Elements ◽  
Renal Tubular ◽  
Splicing Site ◽  
Minigene Assay

Primary distal renal tubular acidosis (dRTA) is a rare tubular disease associated with variants in SLC4A1, ATP6V0A4, ATP6V1B1, FOXⅠ1 or WDR72 genes. Currently, there is growing evidence that all types of exonic variants can alter splicing regulatory elements, affecting the pre-mRNA splicing process. This study was to determine the consequences of variants associated with dRTA on pre-mRNA splicing combined with predictive bioinformatics tools and minigene assay. As a result, among the 15 candidate variants, 8 variants distributed in SLC4A1 (c.1765C>T, p.Arg589Cys), ATP6V1B1( c.368G>T, p.Gly123Val; c.370C>T, p.Arg124Trp; c.484G>T, p.Glu162* and c.1102G>A, p.Glu368Lys) and ATP6V0A4 genes (c.322C>T, p.Gln108*; c.1571C>T, p.Pro524Leu and c.1572G>A, p.Pro524Pro) were identified to result in whole or part of exon skipping by either disruption of ESEs and generation of ESSs, or interference with the recognition of the classic splicing site, or both. To our knowledge, this is the first study on pre-mRNA splicing of exonic variants in the dRTA-related genes. These results highlight the importance of assessing the effects of exonic variants at the mRNA level and suggest that minigene analysis is an effective tool for evaluating the effects of splicing on variants in vitro

A novel variant of the KIF11 gene, c.2922G>T, is associated with Microcephaly by affecting RNA splicing

2021 ◽  
Author(s):  
Zhenglong Guo ◽  
Xiaodong Huo ◽  
Dong Wu ◽  
Bingtao Hao ◽  
Shixiu Liao
Keyword(s):  
Rna Splicing ◽  
Novel Variant

scholarly journals Principles and Practical Considerations for the Analysis of Disease-Associated Alternative Splicing Events Using the Gateway Cloning-Based Minigene Vectors pDESTsplice and pSpliceExpress

2021 ◽  
Vol 22 (10) ◽  
pp. 5154
Author(s):  
Elena Putscher ◽  
Michael Hecker ◽  
Brit Fitzner ◽  
Peter Lorenz ◽  
Uwe Klaus Zettl
Keyword(s):  
Alternative Splicing ◽  
Rna Splicing ◽  
Region Of Interest ◽  
Restriction Enzymes ◽  
Genomic Region ◽  
Gateway Cloning ◽  
Splicing Pattern ◽  
Processing Step ◽  
Alternative Splicing Events ◽  
Minigene Assay

Splicing is an important RNA processing step. Genetic variations can alter the splicing process and thereby contribute to the development of various diseases. Alterations of the splicing pattern can be examined by gene expression analyses, by computational tools for predicting the effects of genetic variants on splicing, and by splicing reporter minigene assays for studying alternative splicing events under defined conditions. The minigene assay is based on transient transfection of cells with a vector containing a genomic region of interest cloned between two constitutive exons. Cloning can be accomplished by the use of restriction enzymes or by site-specific recombination using Gateway cloning. The vectors pDESTsplice and pSpliceExpress represent two minigene systems based on Gateway cloning, which are available through the Addgene plasmid repository. In this review, we describe the features of these two splicing reporter minigene systems. Moreover, we provide an overview of studies in which determinants of alternative splicing were investigated by using pDESTsplice or pSpliceExpress. The studies were reviewed with regard to the investigated splicing regulatory events and the experimental strategy to construct and perform a splicing reporter minigene assay. We further elaborate on how analyses on the regulation of RNA splicing offer promising prospects for gaining important insights into disease mechanisms.

Identification of seven exonic variants in the SLC4A1, ATP6V1B1 and ATP6V0A4 gene that alter RNA splicing by minigene assay.

2021 ◽  
Author(s):  
Ruixiao Zhang ◽  
Zeqing Chen ◽  
Qijing Song ◽  
Sai Wang ◽  
Zhiying Liu ◽  
...  
Keyword(s):  
Rna Splicing ◽  
Minigene Assay

Discovery of a Novel Variant of OCT4, OCT4B3

2016 ◽  
Vol 2 (4) ◽  
pp. 32 ◽  
Author(s):  
Seyed Javad Mowla ◽  
Ensieh Poursani ◽  
Majid Mehravar ◽  
James E. Trosko
Keyword(s):  
Novel Variant

An audit and insights from clinical exome sequencing in psychiatry: genotype-phenotype correlation

2020 ◽  
Author(s):  
Jayant Mahadevan ◽  
Reeteka Sud ◽  
Ravi Kumar Nadella ◽  
Vani P ◽  
Anand G Subramaniam ◽  
...  
Keyword(s):  
Exome Sequencing ◽  
Psychiatric Symptoms ◽  
Pathogenic Variant ◽  
Clinical Exome Sequencing ◽  
Mapt Gene ◽  
Nf1 Gene ◽  
Novel Variant ◽  
History Of ◽  
Atypical Presentations ◽  
Minor Physical Anomalies

BACKGROUND:Psychiatric syndromes have polymorphic symptomatology, and are known to be heritable. Psychiatric symptoms (and even syndromes) often occur as part of the clinical presentation in rare Mendelian syndromes. Clinical exome sequencing reports may help with refining diagnosis and influence treatment decisions, in addition to providing a window into the biology of brain and behaviour. We describe a clinical audit of 12 individuals who sought treatment at our hospital, and for whom targeted sequencing was ordered. Three cases are discussed in detail to demonstrate correlations between genotype and phenotype in the clinic.METHODS:Targeted Next-Generation Sequencing (NGS) was done using Clinical Exome Panel (TruSight One, Illumina) covering coding exons and flanking intronic sequences of 4811 genes associated with known inherited diseases. Variants detected were classified according to the American College for Medical Genetics (ACMG) recommendation for standards of interpretation and reporting of sequence variations.RESULTS:Ten out of twelve cases had at least one pathogenic variant. In one of these cases, we detected a known pathogenic variant in MAPT gene in a suspected FTD case, which helped us to confirm the diagnosis. In another case, we detected a novel variant predicted to be deleterious in NF1 gene. Identification of this mutation suggested a change in treatment for the patient, that was of benefit. The same patient also harboured a novel variant in the TRIO gene. This gene may be involved in biological processes that underlie the patient’s psychiatric illness.CONCLUSIONS:The cases discussed here exemplify different scenarios under which targeted exome sequencing can find meaningful application in the clinic: confirming diagnosis (MAPT variant), or modifying treatment (NF1). We suggest that clinical exome sequencing can be a helpful addition to a clinician’s toolkit when there are expediting factors to consider— such as early-onset, strong family history of mental illness, complex/atypical presentations and minor physical anomalies or neurocutaneous markers.

Sign in / Sign up

Export Citation Format

Share Document